Abstract: Introduction:Hepatic encephalopathy is a reversible neuro-psychiatric syndrome occurring in majority of patients with decompensated chronic liver disease(CLD). Prognosis of Hepatic encephalopathy (HE) depends
Introduction
Hepatic encephalopathy is a potentially reversible neuro-psychiatric and functional syndrome occurring in 50% -70% of patients with advanced liver disease and or porto-systemic shunting [1] .It occurs in presence of insufficient hepatic clearance of toxic products absorbed from intestine resulting in neuro-chemical abnormalities after crossing blood brain barrier [2] Although occurrence of an episode of hepatic encephalopathy appears to be unrelated to the cause of cirrhosis [3] , increases in frequency and severity of such episode predict an increased risk of death [4, 5] .Clinical manifestation of HE range from altered mental status to deep coma [6] . Recurrent episodes of hepatic encephalopathy may be triggered by non-compliance to therapy or precipitated by infection, gastrointestinal bleeding , constipation, high protein diet, dyselectrolytaemia.Current treatment strategies are aimed to reduce serum ammonia by rifaximin or lactulose /lactitol and correcting the precipitating factors. The purpose of this study is to compare the outcome of hepatic encephalopathy in terms of short term mortality and clinical improvement who have a past h/o upper G.I. bleeding and or hepatic encephalopathy versus who have no such past history with7days therapy of lactulose and or rifaximin . 
III. Results
The number and percentage of patients of different etiology of decompensated chronic liver diseases . Alcoholic chronic liver diseases (63.33%) was the most common cause in the study,followed by cryptogenic chronic liver diseases (20%), chronic HBV infection (13.33%),chronic HCV infection (3.33%) (table 1).The cause of clinical deterioration in chronic decompensated liver diseases with hepatic encephalopathy. More common causes of deterioration in our study were chronic HCV (66.67%) and chronic HBV (25%) infection but among the total clinical deteriorations alcoholic chronic liver disease was maximum. But this is not statistically significant (p=0.789) . (Table 2) The patients with past h/o upper G.I .bleeding, clinical deterioration occurred in 26.92% and improvement was 73.08%. But among the patients without having past h/o upper G.I. bleeding , clinical deteriorations occurred only in 2.63% of cases and clinical improvements occurred in 97.37% . This differences of clinical outcome are statistically significant (p =0.002). (Table 3) The patients with past h/o hepatic encephalopathy,clinical deterioration occurred in 31.25% and corresponding percentage of improvement was 68.75%. But among the patients without having past h/o hepatic encephalopathy, clinical deteriorations were nil and clinical improvements were 100 percent and statistically significant (p =0.000). (Table 4 
IV. Discussion
Types of chronic liver diseases: In this study, alcoholic chronic liver diseases(63.33%)was the most common cause of decompensated chronic liver diseases, followed by cryptogenic chronic liver diseases (20%), cirrhosis of liver due to chronic HBV infection (13.33%), HCV infection (3.33%). In Western countries, alcohol abuse remains the most common aetiology of chronic liver diseases with hepatic encephalopathy [11, 12] . But in another study,it is revealed that occurrence of hepatic encephalopathy appears to be unrelated to the cause of cirrhosis [3] Cause specific mortality after treatment: In the study, maximum clinical deteriorations occurred in patients of alcoholic chronic liver disease bu the cause specific clinical deteriorations were more in patients of chronic liver diseases due to chronic HCV infection (66.67%) and chronic HBV infection (25%) .But this apparent differences were not statistically significant ( p = 0.0789) . As the number of patients in different group of patients of decompensated chronic liver diseases were small in size, it is difficult to draw any conclusion. A cross sectional study, published in BMC Gastroenterlogy 2008; 8: 46, showed that type and etiology of cirrhosis of liver are not related to presence of hepatic encephalopathy or not related to quality of life [3] .
Past illness and outcome: About half of the study patients (about 53.33%) had past h/o hepatic encephalopathy and 57.77% of the patients had past h/o hematemesis and or melena. Multiple studies reveal that increases in frequency and severity of such episode of hepatic encephalopathy predict an increased risk of death [4, 5] . From our study it was found that clinical deterioration occurred more in patients having past h/o upper G.I. bleeding (26.92% than in patients without past h/o upper G.I.bleeding(2.63%) and corresponding clinical improvements were 73.08% and 97.37% respectively. This differences of clinical outcome in presence or absence of past h/o upper G.I. bleeding are statistically significant (p=0.002) . The patients with a past h/o similar illness, i.e, hepatic encephalopathy resulted in clinical deteriorations ( 31.25%). On the other hand the patients without past h/o similar illness did not suffer from any clinical deterioration and their corresponding clinical improvements were 68.75% and 100% respectively. This is also statistically significant (p = 0.000) ; so past h/o upper G.I. bleeding and hepatic encephalopathy have significant impact on clinical outcome . There is a study about prognostic significance of hepatic encephalopathy, published in J. Heptol 1999 ; 30: 890-5, which reveals that frequency and severity of hepatic encephalopathy predicts an increased risk of death [ 4, 5] .
V. Conclusion
This study it is revealed that clinical outcome was significantly better in patients of hepatic encephalopathy without past h/o hepatic encephalopathy and upper G. 
